Found 58 matching trials
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
PHASE1Background:
\- The experimental cancer treatment drug AZD6244 has been sho...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
PHASE1The purpose of this platform study is to evaluate the safety, tolerability,...
Location
Banner MD Anderson Cancer Center
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
PHASE2SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Location
Multiple Locations
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
PHASE4This study evaluates prospectively the effects of an anti-angiotensin II re...
Location
"Mater Domini" Hospital
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
PHASE4Idiopathic immunoglobulin A nephropathy (IgAN) is the most common biopsy-pr...
Location
francesco paolo Schena
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
PHASE1This study is a Phase 1 clinical trial testing an oral investigational drug...
Location
Multiple Locations
Treatment of IgA Nephropathy According to Renal Lesions
PHASE3TIGER study (Treatment of IgA nEphropathy according to Renal lesions) is a ...
Location
Hôpital Necker Enfants-malades
Shiga Microalbuminuria Reduction Trial-2
PHASE4The purpose of this study is to compare the effects of a direct renin inhib...
Location
Shiga University of Medical Science
Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
NAThe prevalence of Sickle Cell Associated Nephropathy (SCAN) is increasing a...
Location
Centre de la Drépanocytose, Service de Médecine Interne. Hôpital Tenon, 4 Rue de la Chine
Stopping ACE-inhibitors in COVID-19
PHASE4ACEI-COVID-19 is a multicenter, randomized trial testing the hypothesis tha...
Location
Medical University Innsbruck, University Hospital of Internal Medicine III